IFNAR1 and neoplasm: Using mouse models for tumor transplantation and primary development, it was shown that non-immune-edited (immunogenic) sarcomas grown in rag2-deficient mice (which lack lymphocytes) were rejected by wild-type syngeneic mice; however IFNAR1 blockade abrogated this effect.